Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:43 AM UTC
| NCT Number | NCT05543681 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE2 |
| Target Enrollment | 164 participants |
| Active Locations | 23 sites in the US |
| Sponsor | IGC Pharma, LLC |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 18, 2026: Clinical trial NCT05543681 is currently recruiting participants. This phase2 study for alzheimer's disease is actively seeking new participants at 23 locations across the United States. The study is sponsored by IGC Pharma, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05543681 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05543681 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.